Journal article · 2026 · Open access

PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES

Swathi Ratnam Regidi, Surabhi Johari, Sanskar Singh, Navjot Kaur, Fazil Ahmad, Akkiraju Pavan Chand

Genetics and Molecular Research · Published 5 October 2026 · DOI 10.4238/6p76cf81

Open PDFView at the publisherCite this paper

In brief

“PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES” is a 2026 journal article by Swathi Ratnam Regidi and 5 co-authors, published in Genetics and Molecular Research. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY-SA licence: the full text is free to read at Genetics and Molecular Research.

Citations
0
References
48
Authors
6

Abstract

Through an understanding of the role of inherited and acquired genetic variation in differences in drug metabolism, efficacy and toxicity, pharmacogenomics is changing the landscape of personalized drug therapy. In this review, the molecular and genetic basis of pharmacogenomic variability, clinically relevant biomarkers, enabling technologies, therapeutic applications, implementation pathways, and implications for clinical outcomes will be explored. Collectively, common variants, rare variants, copy-number variants, drug-target variation, and gene environment interactions contribute to pharmacokinetic (PK) and pharmacodynamic (PD) variability. Advances in targeted genotyping, next-generation and long-read sequencing, multi-omics, pharmacomicrobiomics, and artificial intelligence are expanding the ability to identify actionable biomarkers and predict individualized drug responses. The clinical use of genotype-based approaches is becoming increasingly apparent in cardiovascular medicine, oncology, psychiatry, HIV treatment, and transplantation, where genotype-based approaches can assist in drug selection, dose optimization, reduction of drug toxicity, and optimizing treatment response. Factors that continue to limit the translation to routine care include the availability of variable-strength evidence, cost of implementation, clinician preparedness, electronic health record integration, and population diversity. Further advances will require robust multi-gene models that have been validated, clinical decision support systems that can be interoperable across institutions, a more diverse population and the incorporation of genomic data with multi-omics and clinical data. Pharmacogenomics is thus an important avenue for improved precision prescribing, which is safer, more effective and more personalized.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Regidi, S. R., Johari, S., Singh, S., Kaur, N., Ahmad, F., & Chand, A. P. (2026). PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES. Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81

MLA 9

Regidi, Swathi Ratnam, et al. “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES.” Genetics and Molecular Research, 2026. https://doi.org/10.4238/6p76cf81.

Chicago

Regidi, Swathi Ratnam, Surabhi Johari, Sanskar Singh, Navjot Kaur, Fazil Ahmad, and Akkiraju Pavan Chand. 2026. “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES.” Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81.

Harvard

Regidi, S. R. et al. (2026) ‘PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES’, Genetics and Molecular Research. doi:10.4238/6p76cf81.

IEEE

S. R. Regidi, S. Johari, S. Singh, N. Kaur, F. Ahmad, and A. P. Chand, “PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES,” Genetics and Molecular Research, 2026, doi: 10.4238/6p76cf81.

BibTeX

@article{regidi2026pharmacogenomic,
  title     = {{PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES}},
  author    = {Regidi, Swathi Ratnam and Johari, Surabhi and Singh, Sanskar and Kaur, Navjot and Ahmad, Fazil and Chand, Akkiraju Pavan},
  journal   = {Genetics and Molecular Research},
  year      = {2026},
  doi       = {10.4238/6p76cf81},
  url       = {https://doi.org/10.4238/6p76cf81}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • pharmacogenomics
  • individualized drug therapy
  • precision medicine
  • pharmacokinetic variability
  • pharmacodynamic variability
  • genetic variants
  • copy number variation
  • gene-environment interaction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Regidi, S. R., Johari, S., Singh, S., Kaur, N., Ahmad, F., & Chand, A. P. (2026). PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES. Genetics and Molecular Research. https://doi.org/10.4238/6p76cf81

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Genetics and Molecular Research: sign in and open the PDF from this page.

Who wrote this paper?

Swathi Ratnam Regidi, Surabhi Johari, Sanskar Singh, Navjot Kaur, Fazil Ahmad, Akkiraju Pavan Chand.

What is the DOI of this paper?

10.4238/6p76cf81, permanently at https://doi.org/10.4238/6p76cf81. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.